Effect of FAK inhibitor VS‐6063 (defactinib) on docetaxel efficacy in prostate cancer

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles